Minutes of the CHMP meeting 8-11 December 2025
Submitted by Anonymous (not verified) on 25 August 2026 - 10:00
Minutes of the CHMP meeting 8-11 December 2025
Minutes of the CHMP meeting 10-13 November 2025
Submitted by Anonymous (not verified) on 25 August 2026 - 9:59
Minutes of the CHMP meeting 10-13 November 2025
Minutes of the CHMP meeting 13-16 October 2025
Submitted by Anonymous (not verified) on 25 August 2026 - 9:58
Minutes of the CHMP meeting 13-16 October 2025
Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 22, Status: Authorised
Submitted by Anonymous (not verified) on 25 August 2026 - 9:52
Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Date of authorisation: 10/04/2017, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 24 August 2026 - 16:40
Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Date of authorisation: 10/04/2017, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 24 August 2026 - 16:22
Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 24 August 2026 - 16:00
Human medicines European public assessment report (EPAR): Ixchiq, Chikungunya vaccine (live), Date of authorisation: 28/06/2024, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 48, Status: Authorised
Submitted by Anonymous (not verified) on 24 August 2026 - 15:50
Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 48, Status: Authorised
Orphan designation: satralizumab Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease, 22/06/2026 Positive
Submitted by Anonymous (not verified) on 24 August 2026 - 13:56
Orphan designation: satralizumab Treatment of myelin oligodendrocyte glycoprotein antibody-associated disease, 22/06/2026 Positive
Orphan designation: short hairpin RNA against NANOG mRNA Treatment of glioma, 23/06/2026 Positive
Submitted by Anonymous (not verified) on 24 August 2026 - 13:54
Orphan designation: short hairpin RNA against NANOG mRNA Treatment of glioma, 23/06/2026 Positive